Atıf İçin Kopyala
Ulusoy Guzeldemirci N., Cimok S., Das-Evcimen N., Sarikaya M.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.16, sa.1, ss.1-7, 2019 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
16
Sayı:
1
-
Basım Tarihi:
2019
-
Doi Numarası:
10.4274/tjps.05900
-
Dergi Adı:
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.1-7
-
Anahtar Kelimeler:
Hydrazinecarbothioamide, 4-thiazolidinone, imidazo[2,1-b]thiazole, aldose reductase inhibition, ANTICONVULSANT ACTIVITY, BIOLOGICAL-ACTIVITY, INSULIN-RESISTANCE, DERIVATIVES, THIAZOLIDINEDIONES, COMPLICATIONS, NIDDM
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Objectives: To synthesize and characterize 2-[[6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetyl]-N-alkyl/arylhydrazinecarbothioamide and 3-alkyl/aryl-2-[((6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl)acetyl)hydrazono]-5-nonsubstituted/methyl-4-thiazolidinone derivatives and evaluate them for their aldose reductase (AR) inhibitory effect.